Avanos Medical, Inc. $AVNS Shares Sold by Intech Investment Management LLC

Intech Investment Management LLC lowered its holdings in Avanos Medical, Inc. (NYSE:AVNS) by 78.8% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 26,299 shares of the company’s stock after selling 97,762 shares during the period. Intech Investment Management LLC owned approximately 0.06% of Avanos Medical worth $322,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in AVNS. US Bancorp DE grew its stake in shares of Avanos Medical by 7.7% in the first quarter. US Bancorp DE now owns 15,184 shares of the company’s stock worth $218,000 after acquiring an additional 1,091 shares in the last quarter. Cary Street Partners Financial LLC acquired a new position in Avanos Medical during the 1st quarter worth $226,000. Charles Schwab Investment Management Inc. increased its holdings in Avanos Medical by 32.3% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 608,635 shares of the company’s stock worth $8,722,000 after purchasing an additional 148,619 shares during the period. Entropy Technologies LP acquired a new stake in Avanos Medical in the 1st quarter valued at about $254,000. Finally, Nuveen LLC acquired a new stake in Avanos Medical in the 1st quarter valued at about $1,839,000. 95.17% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

AVNS has been the subject of a number of analyst reports. Weiss Ratings reissued a “sell (d)” rating on shares of Avanos Medical in a research report on Tuesday, November 25th. Zacks Research upgraded shares of Avanos Medical to a “hold” rating in a report on Tuesday, August 12th. Finally, Wall Street Zen upgraded shares of Avanos Medical from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 8th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce”.

Avanos Medical Trading Down 0.8%

Shares of AVNS stock opened at $11.74 on Monday. The company has a market capitalization of $544.97 million, a P/E ratio of -1.15 and a beta of 1.09. The company has a current ratio of 2.38, a quick ratio of 1.36 and a debt-to-equity ratio of 0.12. Avanos Medical, Inc. has a twelve month low of $9.30 and a twelve month high of $19.91. The business’s 50 day moving average is $11.48 and its two-hundred day moving average is $11.80.

Avanos Medical (NYSE:AVNS) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.10. The firm had revenue of $177.80 million during the quarter, compared to analysts’ expectations of $164.50 million. Avanos Medical had a positive return on equity of 6.21% and a negative net margin of 67.00%.Avanos Medical’s revenue was up 4.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.33 earnings per share. Avanos Medical has set its FY 2025 guidance at 0.850-0.950 EPS. Equities analysts forecast that Avanos Medical, Inc. will post 1.32 EPS for the current year.

Insider Buying and Selling

In related news, SVP Kerr Holbrook sold 15,000 shares of the stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $11.00, for a total transaction of $165,000.00. Following the transaction, the senior vice president directly owned 83,860 shares in the company, valued at approximately $922,460. This represents a 15.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 2.64% of the company’s stock.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.